🥁 The ACC is now accepting submissions of LBCTs. Submit your research for a chance to be featured on cardiology's main stage & help shape the future of CV medicine by sharing your research with the global CV community at #ACC27-#WCCardio. 🔎 Learn more: bit.ly/3JNubKG

Starting Soon: We're kicking off Day 1️⃣ of the ACC CTR Program! Follow along as participants and faculty come together to advance clinical research through learning, collaboration and broad perspectives. 🔗 bit.ly/48dT3EK #TheFaceofCardiology #cardiology

Non-IRA #revasc in patients w/ #STEMI & multivessel #cvCAD increased from 2018 to 2022. However, most patients did not undergo non-IRA #PCI within 45 days of primary PCI, according to a recent study using data from the ACC's #CathPCIRegistry. 🔗 bit.ly/4yuxoCd #NCDR

New #JACCHF research presented at #HFSA2026 spans several evolving areas in #HeartFailure, from ATTR-CM biomarkers & measures of physical function to predictors of adverse outcomes in transplant recipients, & more. Get full details: bit.ly/47uWTsg #CardioX

🙏 Thank you to the Roundtable Planning Committee, the supporters and all participants for making today’s Roundtable a success and for advancing the conversation towards prevention-proficient health systems and society. bit.ly/4hYYiND #TransformCVCare #cvPrev

What happens in the body when someone with #POTS stands? A new #CardioSmart infographic explains how POTS affects the body, symptoms & why it can interfere with daily activities. Share this patient-friendly resource during Dysautonomia Awareness Month: bit.ly/3W8s6i9

How can we bridge the gap between patients, clinicians & technology to advance earlier #cvPrev? ACC’s Roundtable chaired by @NicoleBhaveMD explores how #ACCInnovation, data & health system transformation can lead to proactive prevention. bit.ly/4hYYiND #TransformCVCare

Dr. @rkwadhera discusses policy as preventive medicine during the PRIME-Heart Roundtable: “The prevention cascade leaks before it starts.” bit.ly/4hYYiND #TransformCVCare #ACCPrev

Visit ACC’s #AI Resource Center for the latest tools and resources on AI, including free access to the AI-Enabled Clinician Podcast and AI in Practice tools. bit.ly/4d2rIF8 #TransformCVCare

At today’s Roundtable @PamTaubMD talks about the continuum in #ASCVD and the importance of focusing #ACCPrev on improving the quality of life: “The whole paradigm needs to change in terms on longevity and prevention.” bit.ly/4hYYiND #TransformCVCare

Check out ACC’s CVD Risk Estimator Plus app: helps estimate 10- and 30-year risks for total #CVD, #ASCVD and #HeartFailure, using the combined strength of the AHA PREVENT™ equations and the previous Pooled Cohort Equations. bit.ly/4s2ptZQ #TransformCVCare #ACCPrev

In a new episode of #ACCEL Lite, Drs. @ditchhaporia and @DLBHATTMD discuss TRANQUILITY: Efficacy of monthly and quarterly dosing of pacibekitug targeting inflammation in CKD with high cardiovascular risk. Listen to the episode: bit.ly/4sobqzy

Dr. Robert Califf discusses prevention vs. wellness and ways to bridge the gap: “CVD accounts for a significant portion of our chasm between what is possible for healthy longevity and the current status of health in the U.S.” bit.ly/4hYYiND #TransformCVCare #ACCPrev

Looking for more patient resources on #ACCPrev? Check out #CardioSmart’s Healthy Living hub, offering infographics and patient tools on heart-healthy nutrition, stress management, and ways to stay active and up-to-date with immunizations. bit.ly/3kZfLWz #TransformCVCare

Dr. Robert Califf addresses #ACCPrev at today’s Roundtable: “Most of the gap can be closed by simple, well-known, repetitive behaviors that are very difficult to sustain in the U.S. environment, particularly for disadvantaged people.” bit.ly/4hYYiND #TransformCVCare

ACC’s PRIME-Heart Initiative equips clinicians to deliver more predictive & equitable CV care by focusing on 3 strategic areas: earlier risk detection, risk-guided, sequenced interventions, & clinical translation & integration. bit.ly/4nAhgd5 #ACCPrev #TransformCVCare

#ACCPresident @Drroxmehran kicks off today’s Heart House Roundtable on Taking Action to Advance Life Course #ASCVD Prevention. Stay tuned for more on #ACCPrev. bit.ly/4hYYiND #TransformCVCare

Today at Heart House experts are gathering for the 3rd Roundtable in the PRIME-Heart Initiative series to explore how evolving care experiences can drive a shift toward earlier, more proactive #ASCVD prevention across health care. bit.ly/4hYYiND #TransformCVCare #ACCPrev

Drs. Joud Fahed, @rblument1, and @priyaumapathi explore recent guidelines on Cardiovascular-Kidney-Metabolic Syndrome in a new expert analysis: bit.ly/3UxjFwB #ACCPrev #CardioX

Patients with CV disease face increased risks from infections like flu, RSV, COVID-19, pneumococcal disease & shingles. 💉Vaccination is an evidence-based way to help reduce infection-related CV complications. Explore patient & clinician resources: bit.ly/4zaoOJD @GSK

4️⃣ late-breaking trials presented at #ESCCongress 2026 focused on post #cvACS antithrombotic therapy: ✅ LIBREXIA ACS ✅ PREMIUM ✅ SWITCH SWEDEHEART ✅ A-CLOSE Learn more about the findings: bit.ly/4jvjtbg #CardioX